Your browser doesn't support javascript.
loading
STK33 participates to HSP90-supported angiogenic program in hypoxic tumors by regulating HIF-1α/VEGF signaling pathway.
Liu, Yang; Steinestel, Konrad; Rouhi, Arefeh; Armacki, Milena; Diepold, Kristina; Chiosis, Gabriela; Simmet, Thomas; Seufferlein, Thomas; Azoitei, Ninel.
Afiliación
  • Liu Y; Center for Internal Medicine I, Ulm University, Ulm, Germany.
  • Steinestel K; Department of Gastroenterology and Hepatology, Zhongda Hospital, Southeast University, Nanjing, China.
  • Rouhi A; Institute of Pathology and Molecular Pathology, Bundeswehrkrankenhaus Ulm, Ulm, Germany.
  • Armacki M; Gerhard-Domagk-Institute of Pathology, University of Münster, Münster, Germany.
  • Diepold K; Center for Internal Medicine III, Ulm University, Ulm, Germany.
  • Chiosis G; Center for Internal Medicine I, Ulm University, Ulm, Germany.
  • Simmet T; Center for Internal Medicine I, Ulm University, Ulm, Germany.
  • Seufferlein T; Department of Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Institute, New York, NY, USA.
  • Azoitei N; Institute of Pharmacology of Natural Products & Clinical Pharmacology, Ulm University, Ulm, Germany.
Oncotarget ; 8(44): 77474-77488, 2017 Sep 29.
Article en En | MEDLINE | ID: mdl-29100402
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Alemania